Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer
Angélica Aponte-López, Ezequiel M. Fuentes‐Pananá, Daniel Cortes-Muñoz, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-11
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1194
Tumor Immunology and Tumor Evolution: Intertwined Histories
Jérôme Galon, Daniela Bruni
Immunity (2020) Vol. 52, Iss. 1, pp. 55-81
Open Access | Times Cited: 454
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
Tyler Risom, David R. Glass, Inna Averbukh, et al.
Cell (2022) Vol. 185, Iss. 2, pp. 299-310.e18
Open Access | Times Cited: 260
Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
Reem Saleh, Eyad Elkord
Seminars in Cancer Biology (2019) Vol. 65, pp. 13-27
Closed Access | Times Cited: 222
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Vincenzo Salemme, Giorgia Centonze, Federica Cavallo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 182
Exosomes and their role in tumorigenesis and anticancer drug resistance
Neta Milman, Lana Ginini, Ziv Gil
Drug Resistance Updates (2019) Vol. 45, pp. 1-12
Closed Access | Times Cited: 178
Mast Cells: A New Frontier for Cancer Immunotherapy
Jake Lichterman, Sangeetha M. Reddy
Cells (2021) Vol. 10, Iss. 6, pp. 1270-1270
Open Access | Times Cited: 104
Mast Cells in the Tumor Microenvironment
Angélica Aponte-López, Samira Muñoz-Cruz
Advances in experimental medicine and biology (2020), pp. 159-173
Closed Access | Times Cited: 127
Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology
Mariana Segovia‐Mendoza, Jorge Morales‐Montor
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 115
Histamine receptors and cancer pharmacology: an update
N Massari, Melisa B. Nicoud, Vanina A. Medina
British Journal of Pharmacology (2018) Vol. 177, Iss. 3, pp. 516-538
Open Access | Times Cited: 101
Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients
Jing Feng, Fuya Zhao, Jiayu Sun, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 11, pp. 2728-2745
Open Access | Times Cited: 93
Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth
Alastair M. McKee, Benjamin Kirkup, Matthew Madgwick, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103012-103012
Open Access | Times Cited: 59
Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors
Maria Teresa Majorini, Mario P. Colombo, Daniele Lecis
Cancer Research (2022) Vol. 82, Iss. 8, pp. 1439-1447
Open Access | Times Cited: 40
The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers
Anna Sobiepanek, Łukasz Kuryk, Mariangela Garofalo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2249-2249
Open Access | Times Cited: 39
Mast Cells as a Target—A Comprehensive Review of Recent Therapeutic Approaches
Joanna Baran, Anna Sobiepanek, Anna Mazurkiewicz-Pisarek, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1187-1187
Open Access | Times Cited: 29
Immune landscape of breast tumors with low and intermediate estrogen receptor expression
Leonie Voorwerk, Joyce Sanders, Milou S. Keusters, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer
Ana I. Matos, Bárbara Carreira, Carina Peres, et al.
Journal of Controlled Release (2019) Vol. 307, pp. 108-138
Closed Access | Times Cited: 55
The immunomodulatory effects of endocrine therapy in breast cancer
Huanhuan Huang, Jun Zhou, Hailong Chen, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 51
A review concerning the breast cancer-related tumour microenvironment
Oscar Hernán Rodríguez-Bejarano, Carlos Parra-López, Manuel A. Patarroyo
Critical Reviews in Oncology/Hematology (2024) Vol. 199, pp. 104389-104389
Open Access | Times Cited: 6
Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms
Zhiqiao Zhang, Jing Li, Tingshan He, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 44
Impact of immune cells on the hallmarks of cancer: A literature review
Alexandra C. Costa, Joana Santos, Rui M. Gil da Costa, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 168, pp. 103541-103541
Closed Access | Times Cited: 40
Angiogenesis induction in breast cancer: A paracrine paradigm
Nilaja Badodekar, Akshita Sharma, Vikrant R. Patil, et al.
Cell Biochemistry and Function (2021) Vol. 39, Iss. 7, pp. 860-873
Closed Access | Times Cited: 37
Proteomics and its applications in breast cancer.
Anca-Narcisa Neagu, Danielle Whitham, Emma Buonanno, et al.
PubMed (2021) Vol. 11, Iss. 9, pp. 4006-4049
Closed Access | Times Cited: 34
Controversial role of mast cells in breast cancer tumor progression and angiogenesis
Doménico Ribatti, Tiziana Annese, Roberto Tamma
Clinical Breast Cancer (2021) Vol. 21, Iss. 6, pp. 486-491
Closed Access | Times Cited: 33
Depression in breast cancer patients: Immunopathogenesis and immunotherapy
Sheng Yu, Wen Li, Lingxue Tang, et al.
Cancer Letters (2022) Vol. 536, pp. 215648-215648
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top